The Effectiveness of Telerehabilitation in Liver Transplant Patients
Investigation of the Effectiveness of the Telerehabilitation Program in Patients With Liver Transplantation
1 other identifier
interventional
58
1 country
1
Brief Summary
Liver transplantation is defined as a surgical procedure in which a liver with tissue damage and inability to perform its functions is replaced, in whole or in part, with a healthy liver obtained from a living or deceased donor. Post-transplantation treatment includes medical treatment, physiotherapy, and rehabilitation. Physiotherapy and rehabilitation, an important component of liver transplantation management, consists of three phases: preoperative, early postoperative, and late postoperative. Telerehabilitation is currently defined as the control or monitoring of rehabilitation remotely using telecommunication-related technologies. Studies on telerehabilitation in liver transplant patients are insufficient in the literature. The aim of this study is to investigate the effect of a telerehabilitation-based exercise program applied to liver transplant patients on exercise capacity, respiratory muscle strength, peripheral muscle strength, fatigue level and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
January 12, 2026
December 1, 2025
5 months
December 24, 2025
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
6-Minute Walk Test
Exercise capacity will be assessed using the Six-Minute Walk Test, which plays an important role in evaluating pre- and post-operative exercise performance in liver transplant patients. The test will be conducted in a 30 m long, enclosed, straight corridor under the supervision of a physiotherapist, in accordance with the criteria set by the American Thoracic Society. The patients' heart rate and peripheral capillary oxygen saturation values will be recorded before, during, and after the test using a portable pulse oximeter. Dyspnea and perceived fatigue levels will be assessed using the Modified Borg Scale (MBS) during the test. The total walking distance completed in six minutes will be recorded in meters as the individual's six-minute walk distance
eight weeks
Timed Up and Go Test
Used to evaluate the balance performance of individuals during movement. The person sits in a chair of standard height (46 cm), a distance of 3 meters is measured from the chair and a cone is placed at the end of this distance to indicate it. After receiving the command "walk as fast as you can and sit back down in the chair," the person gets up, walks down the corridor for meters, turns around, walks back to the chair and sits down. The time from the moment of getting up from the chair until the person turns around and sits back down in the chair is measured with a stopwatch and recorded in seconds.
eight weeks
Secondary Outcomes (4)
The Liver Disease Symptom Index 2.0
eight weeks
The Fatigue Severity Scale
eight weeks
Respiratory Muscle Strength Measurement
eight weeks
Muscle Strength Measurement
eight weeks
Study Arms (2)
Telerehabilitation group
EXPERIMENTALThe telerehabilitation group will receive videoconference-based telerehabilitation three days a week for eight weeks. All exercises will be performed under the supervision of a physiotherapist.
Home exercise program group
ACTIVE COMPARATORHome exercise program group will initially be given instructions on the exercises and asked to perform them three days a week for eight weeks. They will be contacted by phone once a week to inquire whether they are doing the exercises.
Interventions
Patients will be given brochures on breathing, strengthening, balance and walking exercises and asked to perform them without a physiotherapist.
The telerehabilitation program will include breathing, strengthening, balance, and walking exercises, with increasing intensity week by week, and stretching exercises targeting major muscles will be given during the cool-down period.
Eligibility Criteria
You may qualify if:
- Being between 18-65 years of age and having undergone a liver transplant
- Having had a liver transplant operation at least 6 months prior
- Spontaneous breathing
- Hemodynamic stability
- Reading and writing skills
- Ability to mobilize independently, ability to follow verbal and visual instructions
You may not qualify if:
- Presence of unstable cardiovascular disease
- Presence of primary lung disease requiring regular bronchodilator treatment
- Presence of neuromuscular disease or neurological complications
- Musculoskeletal limitation/use of assistive devices
- Being a multiple organ transplant recipient
- Presence of orthopedic disability and functional capacity limitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University-Cerrahpasa, Faculty of Health Sciences, Physiotherapy and Rehabilitation Laboratory
Büyükçekmece, Istanbul, 34500, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Our study has two groups. The results will be evaluated by a blinded researcher who does not know which group they are assigned to.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
December 24, 2025
First Posted
January 8, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
January 12, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share